Sign in

CIK 0001069530

  • Non-accelerated filer
  • Smaller reporting company

FILANA THERAPEUTICS, INC.

Sign in to watch
Ticker
FLNA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
911911336
Phone
+1 512-501-2444
Business address
6801 N CAPITAL OF TEXAS HIGHWAY, BUILDING 1; SUITE 300, AUSTIN, TX, 78731
Former names
CASSAVA SCIENCES INC, PAIN THERAPEUTICS INC
  1. 4 Open-market buy 10% owner bought 4,800 shares at $8.39 ($40,272)
  2. 4 Open-market sale Chief Financial Officer sold 10,000 shares at $8.54 ($85,400)
  3. 4 Open-market buy 10% owner bought 102,295 shares at an average $8.48 ($867,760)
  4. 4 Open-market buy 10% owner bought 46,600 shares at $8.61 ($401,226)
  5. 4 Open-market buy 10% owner bought 3,400 shares at $8.73 ($29,682)
  6. 4 Open-market buy 10% owner bought 154,003 shares at an average $8.75 ($1,347,925)
  7. 4 Open-market sale Chief Operating & Med. Officer sold 4,000 shares at $8.90 ($35,600)
  8. 4 Open-market buy 10% owner bought 2,000 shares at $8.64 ($17,280)
  9. 4 Open-market buy 10% owner bought 4,043 shares at an average $8.64 ($34,928)
  10. 4 Open-market sale Chief Financial Officer sold 10,000 shares at $8.60 ($86,000)
  11. 4 Open-market sale Chief Operating & Med. Officer sold 4,000 shares at $9.13 ($36,520)
  12. 4 Open-market sale Chief Financial Officer sold 10,000 shares at $8.55 ($85,500)
  13. 4 Open-market sale President and CEO sold 35,000 shares at $8.55 ($299,250)
  14. 4 Open-market sale Chief Operating & Med. Officer sold 4,000 shares at $8.59 ($34,360)
  15. 4 Gift Chief Financial Officer gave 4,000 shares (gift)
  16. 4/A Open-market buy 10% owner bought 0 shares
  17. 4 Open-market buy 10% owner bought 67,700 shares at $17.89 ($1,211,153)
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 24 of 30 · 591 filings